Becker Patrice M, Waltenberger Johannes, Yachechko Robin, Mirzapoiazova Tamara, Sham James S K, Lee Chun Geun, Elias Jack A, Verin Alexander D
Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Md, USA.
Circ Res. 2005 Jun 24;96(12):1257-65. doi: 10.1161/01.RES.0000171756.13554.49. Epub 2005 May 26.
Neuropilin-1 (Npn-1) is a cell surface receptor that binds vascular endothelial growth factor (VEGF), a potent mediator of endothelial permeability, chemotaxis, and proliferation. In vitro, Npn-1 can complex with VEGF receptor-2 (VEGFR2) to enhance VEGFR2-mediated endothelial cell chemotaxis and proliferation. To determine the role of Npn-1/VEGFR2 complexes in VEGF-induced endothelial barrier dysfunction, endothelial cells were stably transfected with Npn1 or VEGFR2 alone (PAE/Npn and PAE/KDR, respectively), or VEGFR2 and Npn-1 (PAE/KDR/Npn-1). Permeability, estimated by measurement of transendothelial electrical resistance (TER), of PAE/Npn and PAE/KDR cell lines was not altered by VEGF165. In contrast, TER of PAE/KDR/Npn-1 cells decreased in dose-dependent fashion following VEGF165 (10 to 200 ng/mL). Activation of VEGFR2, and 2 downstream signaling intermediates (p38 and ERK1/2 MAPK) involved in VEGF-mediated permeability, also increased in PAE/KDR/Npn-1. Consistent with these data, inhibition of Npn-1, but not VEGFR2, attenuated VEGF165-mediated permeability of human pulmonary artery endothelial cells (HPAE), and VEGF121 (which cannot ligate Npn-1) did not alter TER of HPAE. Npn-1 inhibition also attenuated both VEGF165-mediated pulmonary vascular leak and activation of VEGFR2, p38, and ERK1/2 MAPK, in inducible lung-specific VEGF transgenic mice. These data support a critical role for Npn-1 in regulating endothelial barrier dysfunction in response to VEGF and suggest that activation of distinct receptor complexes may determine specificity of cellular response to VEGF.
神经纤毛蛋白-1(Npn-1)是一种细胞表面受体,可结合血管内皮生长因子(VEGF),后者是内皮细胞通透性、趋化性和增殖的强效介质。在体外,Npn-1可与VEGF受体-2(VEGFR2)形成复合物,以增强VEGFR2介导的内皮细胞趋化性和增殖。为了确定Npn-1/VEGFR2复合物在VEGF诱导的内皮屏障功能障碍中的作用,分别将内皮细胞稳定转染单独的Npn1或VEGFR2(分别为PAE/Npn和PAE/KDR),或VEGFR2和Npn-1(PAE/KDR/Npn-1)。通过测量跨内皮电阻(TER)评估的PAE/Npn和PAE/KDR细胞系的通透性,未因VEGF165而改变。相比之下,VEGF165(10至200 ng/mL)作用后,PAE/KDR/Npn-1细胞的TER呈剂量依赖性降低。参与VEGF介导的通透性的VEGFR2及2种下游信号中间体(p38和ERK1/2 MAPK)的激活,在PAE/KDR/Npn-1中也增加。与这些数据一致,抑制Npn-1而非VEGFR2,可减弱VEGF165介导的人肺动脉内皮细胞(HPAE)的通透性,且VEGF121(不能结合Npn-1)未改变HPAE的TER。在可诱导的肺特异性VEGF转基因小鼠中,抑制Npn-1也减弱了VEGF165介导的肺血管渗漏以及VEGFR2、p38和ERK1/2 MAPK的激活。这些数据支持Npn-1在调节对VEGF的内皮屏障功能障碍中起关键作用,并表明不同受体复合物的激活可能决定细胞对VEGF反应的特异性。